Shaping the future
Advancing human potential through frontier research in neural interfaces, performance engineering, and disease eradication.
Shaping the future
Advancing human potential through frontier research in neural interfaces, performance engineering, and disease eradication.
Redefining What’s Possible
The Thompson Institute of Technology and Science (TITS) is a specialized research and education facility focused on the integration of neuroscience, computational biology, and advanced engineering to redefine human limits. Established to address fundamental challenges in cognitive enhancement, physiological optimization, and disease intervention, TITS operates at the intersection of brain science and technological innovation.
Neural Interfaces and Cognitive Augmentation
Development of direct brain-computer interfaces (BCIs) for real-time neural modulation. Current projects include high-resolution neural mapping for enhanced decision-making and adaptive learning systems.
Superhuman Performance Engineering
Quantitative modeling of human physiology under extreme conditions. Research encompasses biomechanical enhancements, metabolic reprogramming, and neuropharmacological interventions to achieve sustained peak performance.
Disease Eradication and Regenerative Health
Genomic and proteomic approaches to eliminate chronic diseases at the molecular level. Initiatives target neurodegenerative diseases, cancer, and metabolic disorders through CRISPR-based editing, AI-accelerated drug discovery, and patient-derived organoid models for precision therapeutics.
Jamin Thompson is an American actor, scientist, and entrepreneur. He is the founder and CEO of Deimos-One; founder, owner, and product architect of Starlab, Redshift, and Fifty Fathoms; and president of the Thompson Foundation.